Figure 3 — Impact of liver metastases status on survival outcomes of first-line immunotherapy in extensive stage small cell lung cancer: a systematic review and meta-analysis

Research Paper|Volume 15, Issue 18|pp. 9561–9571

Impact of liver metastases status on survival outcomes of first-line immunotherapy in extensive stage small cell lung cancer: a systematic review and meta-analysis

Back to articleFigure 3(3 of 8)

100%

Figure 3.Forest plot displaying hazard ratios for comparing progression-free survival between immuno-chemotherapy and chemotherapy. (A) Patients with liver metastases. (B) Patients without liver metastases.